Nicotine Replacement Therapy for Patients With Coronary Artery Disease

Archives of Internal Medicine

Volumn 154, Issue 9, 1994, Pages 989-995

[No Author Info available]

Author keywords

[No Author keywords available]

Indexed keywords

CARBON MONOXIDE; NICODERM 14; NICOTINE; PLACEBO; UNCLASSIFIED DRUG;

ADULT; AGED; ANGINA PECTORIS; ARTICLE; CIGARETTE SMOKING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; HEART ARRHYTHMIA; HEART PALPITATION; HUMAN; MAJOR CLINICAL STUDY; MALAISE; MALE; MULTICENTER STUDY; NAUSEA; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SMOKING CESSATION; ST SEGMENT DEPRESSION; SUBSTITUTION THERAPY; THORAX PAIN; TRANSDERMAL DRUG ADMINISTRATION; WITHDRAWAL SYNDROME;

ADMINISTRATION, CUTANEOUS; ANALYSIS OF VARIANCE; CORONARY DISEASE; DOUBLE-BLIND METHOD; ELECTROCARDIOGRAPHY, AMBULATORY; FEMALE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NICOTINE; PILOT PROJECTS; SMOKING; SMOKING CESSATION; TREATMENT OUTCOME;

EID: 23444445755     PISSN: 00039926     EISSN: 15383679     Source Type: Journal    
DOI: 10.1001/archinte.1994.00420090063007     Document Type: Article

References (14)

1. The Health Benefits of Smoking Cessation: A Report of the Surgeon General. Washington, DC: US Dept of Health and Human Services; 1990. Publication CDC 90-8416.
2. Abelin T, Buehler A, Muller P, Vesanen K, Imhof PR. Controlled trial of transdermal nicotine patch in tobacco withdrawal. Lancet. 1989;1:7-10.
3. Transdermal Nicotine Study Group. Transdermal nicotine for smoking cessation. JAMA. 1991;266:3133-3138.
4. Tonnesen P, Norregaard J, Simonson K, Sawe U. A double-blind trial of a 16-hour transdermal nicotine patch in smoking cessation. N Engl J Med. 1991; 325:311-315.
5. Benowitz NL, Jacob P III, Savanapridi C. Determinants of nicotine intake while chewing nicotine polacrilex gum. Clin Pharmacol Ther. 1987;41:467-473.
6. Gorsline J, Benowitz NL, Rolf CN, Gupta SK, Garaud JJ. Comparison of plasma nicotine concentrations for nicotine transdermal system (NTS), cigarette smoking, and nicotine polacrilex (nicotine gum). Clin Pharmacol Ther. 1992;51:129. Abstract.
7. Fagerstrom KO, Schneider NG. Measuring nicotine dependence: a review of the Fagerstrom Tolerance Questionnaire. J Behav Med. 1982;12:159-182.
8. Minnesota Heart Health Program. Quit and Win Participant Manual: Consumer's Guide to Smoking Cessation. Minneapolis: Regents of the University of Minnesota; 1989.
9. Benowitz NL. Pharmacologic aspects of cigarette smoking and nicotine addiction. N Engl J Med. 1988;319:1318-1330.
10. Kaijser L, Berglund B. Effect of nicotine on coronary blood-flow in man. Clin Physiol. 1985;5:541-552.
11. Maouad J, Fernandez F, Barrillon A, Gerbaux A, Gay J. Diffuse or segmental narrowing (spasm) of the coronary arteries during smoking demonstrated on angiography. Am J Cardiol. 1984;53:354-355.
12. Sheps DS, Herbst MC, Hinderliter AL, et al. Production of arrhythmias by elevated carboxyhemoglobin in patients with coronary artery disease. Ann Intern Med. 1990;113:343-351.
13. The Health Consequences of Smoking: Nicotine Addiction: A Report of the Surgeon General. Washington, DC: US Dept of Health and Human Services; 1988. Publication CDC 88-8406.
14. American Psychiatric Association, Committee on Nomenclature and Statistics. Diagnostic and Statistical Manual of Mental Disorders, Revised Third Edition. Washington, DC: American Psychiatric Association; 1987.